Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Christer Nilsson, MD, Erik Hulegårdh, MD, Vladimir Lazarevic, MD, Hege Garelius, MD, Asa Rangert Derolf, MDPhD, Lars Möllgård, MDPhD, Lovisa Wennström, MD PhD, Bertil Uggla, MD PhD, Petar Antunovic, MD, Kristina Myhr-Eriksson, MD, Anders Wahlin, MD PhD, Martin Höglund, MDPhD, Gunnar Juliusson, MD PhD, Dick Stockelberg, MD PhD, Lehmann Soren, MD PhD

Blood (2014) 124 (21): 281.

https://doi.org/10.1182/blood.V124.21.281.281

Published: 2014

Journal Articles

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Gunnar Juliusson, MD PhD, Vladimir Lazarevic, MD, Sören Lehmann, MD PhD, Åsa Rangert Derolf, MD PhD, Lars Möllgård, MDPhD, Hege Garelius, MD, Lovisa Wennström, MD PhD, Bertil Uggla, MD PhD, Petar Antunovic, MD, Kristina Myhr-Eriksson, MD, Anders Wahlin, MD PhD, Martin Höglund, MDPhD

Blood (2014) 124 (21): 2269.

https://doi.org/10.1182/blood.V124.21.2269.2269

Published: 2014

Journal Articles

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Soren Lehmann, MD, PhD, Vladimir Lazarevic, MD, Ann-Sofi Hörstedt, Erik Hulegårdh, MD, Christer Nilsson, MD, Petar Antunovic, MD, Åsa Rangert Derolf, MD, PhD, Lars Möllgård, MD, PhD, Bertil Uggla, MD, PhD, Lovisa Vennström, MD, Anders Wahlin, MD, PhD, Martin Hoglund, MD, PhD, Dick Stockelberg, MD, PhD, Gunnar Juliusson, MD, PhD

Blood (2012) 120 (21): 130.

https://doi.org/10.1182/blood.V120.21.130.130

Published: 2012

Journal Articles

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Sigurdur Y. Kristinsson, MD, PhD, Tang Min, PhD, Ruth Pfeiffer, PhD, Magnus Björkholm, MD, PhD, Lynn Goldin, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, MD, PhD

Blood (2010) 116 (21): 4053.

https://doi.org/10.1182/blood.V116.21.4053.4053

Published: 2010

Journal Articles

Copy Number Variations In Acute Leukemia with Cytogenetically Detected 11q23 Rearrangements

Irina Golovleva, Pia Lundberg, Erik Forestier, Anders Wahlin, MD, PhD

Blood (2010) 116 (21): 4835.

https://doi.org/10.1182/blood.V116.21.4835.4835

Published: 2010

Journal Articles

Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.

Sigurdur Y Kristinsson, M.D., Ph.D., Ruth Pfeiffer, PhD, Magnus Bjorkholm, MD, PhD, Lynn R Goldin, PhD, Sam Schulman, MD, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, M.D., Ph.D.

Blood (2009) 114 (22): 1872.

https://doi.org/10.1182/blood.V114.22.1872.1872

Published: 2009

Journal Articles

Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden.

Sigurdur Y Kristinsson, M.D., Magnus Bjorkholm, MD, PhD, Lynn R. Goldin, Ph.D., Cecilie Blimark, M.D., Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, M.D., Ph.D.

Blood (2008) 112 (11): 1678.

https://doi.org/10.1182/blood.V112.11.1678.1678

Published: 2008

Journal Articles

Increased Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Lymphoproliferative Tumors among 14689 First-Degree Relatives of 4488 MGUS Patients in Sweden.

Ola Landgren, MD, PhD, Sigurdur Y. Kristinsson, MD, Lynn R. Goldin, PhD, Neil E. Caporaso, MD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Magnus Bjorkholm, MD, PhD, Ingemar Turesson, MD, PhD

Blood (2007) 110 (11): 660.

https://doi.org/10.1182/blood.V110.11.660.660

Published: 2007

NARROW

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Copy Number Variations In Acute Leukemia with Cytogenetically Detected 11q23 Rearrangements

Arterial and Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Population-Based Study.

Familial Aggregation of Multiple Myeloma and Its Precursor Monoclonal Gammopathy of Undetermined Significance (MGUS): A Population-Based Study in Sweden.

Increased Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Lymphoproliferative Tumors among 14689 First-Degree Relatives of 4488 MGUS Patients in Sweden.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only